Human immunodeficiency virus infections: considerations for health care workers.

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26

Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA (1986) 4.25

Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol (1975) 4.23

Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25

Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet (1986) 2.92

Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol (1982) 2.62

Cryptosporidiosis in hospital personnel. Evidence for person-to-person transmission. Ann Intern Med (1985) 2.19

Horizontal transmission of HIV infection between two siblings. Lancet (1986) 2.17

Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. Ann Intern Med (1985) 2.15

Incidence and risk of transmission of HTLV III infections to staff at a London hospital, 1982-85. J Hosp Infect (1985) 2.04

Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med (1986) 1.89

Prevalence of HTLV-III antibody in American blood donors. N Engl J Med (1985) 1.88

Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Ann Intern Med (1985) 1.82

HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury. N Engl J Med (1986) 1.80

Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. JAMA (1985) 1.76

Needlestick HIV seroconversion in a nurse. Lancet (1986) 1.66

Risk of AIDS to health care workers. Br Med J (Clin Res Ed) (1986) 1.43

Low sensitivity of ELISA testing in early HIV infection. N Engl J Med (1986) 1.37

HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA (1985) 1.31

Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.29

Acquired immunodeficiency syndrome (AIDS) in an economically disadvantaged population. Arch Intern Med (1985) 1.12

Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients. Tubercle (1986) 1.07

Lack of antibodies to HTLV-III/LAV in Danish dentists. JAMA (1986) 1.07

Survey of attitudes of nurses working with AIDS patients. Gen Hosp Psychiatry (1987) 1.05

Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med (1985) 0.87

HTLV-III exposure during cardiopulmonary resuscitation. N Engl J Med (1985) 0.85

Needle-stick injuries during the care of patients with AIDS. N Engl J Med (1984) 0.83

Risk of seroconversion for acquired immunodeficiency syndrome (AIDS) in San Francisco health workers. J Occup Med (1986) 0.83

Seronegative 18 months after being bitten by a patient with AIDS. JAMA (1986) 0.82

HTLV-III transmission. JAMA (1985) 0.77

An evaluation of the acquired immunodeficiency syndrome (AIDS) reported in health-care personnel--United States. MMWR Morb Mortal Wkly Rep (1983) 0.77

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med (2001) 6.76

Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41

Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02

Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol (1995) 2.97

Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg (1989) 2.79

Impact of color blindness on recognition of blood in body fluids. Arch Intern Med (2001) 2.78

Serodiagnosis in early Lyme disease. J Clin Microbiol (1993) 2.69

Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69

Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69

Infection due to Leuconostoc species: six cases and review. Rev Infect Dis (1990) 2.58

Lyme borreliosis. Lancet (1998) 2.57

Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44

Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35

Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31

Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med (1993) 2.30

Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis (1997) 2.26

Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med (1985) 1.99

Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98

Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis (2001) 1.94

Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun (2001) 1.93

Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis (2001) 1.84

Leuconostoc, an emerging vancomycin-resistant pathogen. Lancet (1987) 1.80

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis (1995) 1.75

Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (1996) 1.73

Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch Intern Med (1996) 1.71

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64

Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg (1997) 1.63

Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med (1987) 1.61

High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect (2012) 1.60

Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med (1998) 1.60

Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med (1986) 1.60

Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome. Ann Intern Med (1983) 1.58

Serratia plymuthica sepsis associated with infection of central venous catheter. J Clin Microbiol (1987) 1.57

Effect of New York State's do-not-resuscitate legislation on in-hospital cardiopulmonary resuscitation practice. Am J Med (1990) 1.48

'Normal' CSF in bacterial meningitis. JAMA (1980) 1.46

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood (1992) 1.46

Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. Am J Epidemiol (1999) 1.46

Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med (1990) 1.46

Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases. Am J Gastroenterol (1985) 1.45

Trimethoprim-sulfamethoxazole in the United States. Ann Intern Med (1979) 1.45

Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1987) 1.44

Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status. JPEN J Parenter Enteral Nutr (1991) 1.44

The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med (1996) 1.42

False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet (1996) 1.42

Brief report: cerebral syphilitic gumma confirmed by the polymerase chain reaction in a man with human immunodeficiency virus infection. N Engl J Med (1994) 1.41

Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest (1989) 1.40

Tolerability, safety, and acceptability of zidovudine prophylaxis in health care workers. Arch Intern Med (1995) 1.40

Leukopenia, thrombocytopenia, and Lyme borreliosis: is there an association? Clin Infect Dis (1997) 1.40

Central nervous system involvement in patients with acquired immune deficiency syndrome (AIDS). Acta Neurol Scand (1985) 1.39

Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med (2009) 1.38

Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med (1999) 1.30

Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol (2000) 1.29

Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med (1999) 1.27

Opportunistic infections in prisoners. N Engl J Med (1982) 1.22

Cardiobacterium hominis: review of microbiologic and clinical features. Rev Infect Dis (1983) 1.21

Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol (1997) 1.21

Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis (1998) 1.19

Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med (1992) 1.18

Poorly encapsulated Cryptococcus neoformans from patients with AIDS. I: Preliminary observations. AIDS Res (1986) 1.18

Failure of treatment with cephalexin for Lyme disease. Arch Fam Med (2000) 1.15

Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med (1993) 1.12

Acquired immunodeficiency syndrome (AIDS) in an economically disadvantaged population. Arch Intern Med (1985) 1.12

Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs (1982) 1.12

Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. J Clin Microbiol (1997) 1.12

Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guérin: recent Mycobacterium tuberculosis infection or booster effect? Am J Infect Control (1995) 1.11

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis (2001) 1.11

Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi. Infect Immun (2000) 1.10

Effects of OspA vaccination on Lyme disease serologic testing. J Clin Microbiol (1999) 1.08

Prospective evaluation of heart block complicating early Lyme disease. Pacing Clin Electrophysiol (1992) 1.07

Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients. Tubercle (1986) 1.07

Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1993) 1.06

Infected gangrene. A serious complication of peripheral vasopressin administration. Am J Gastroenterol (1980) 1.06

Estimation of the incidence of Lyme disease. Am J Epidemiol (1998) 1.05

Predictive value of a screening test for antibodies to HTLV-III. Am J Clin Pathol (1986) 1.05

Survey of attitudes of nurses working with AIDS patients. Gen Hosp Psychiatry (1987) 1.05

Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods. J Clin Microbiol (2001) 1.04

Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays. J Clin Microbiol (1994) 1.04

Cutaneous necrosis following peripheral intravenous vasopressin therapy. Cutis (1982) 1.04

How common is HTLV-III infection in the United States? N Engl J Med (1985) 1.03

Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med (1997) 1.02

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother (1995) 1.02

Leukemia following treatment of germ cell tumors in men. J Clin Oncol (1984) 1.01

Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans. Eur J Clin Microbiol Infect Dis (2011) 1.00

Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol (2001) 1.00

Entomologic and demographic correlates of anti-tick saliva antibody in a prospective study of tick bite subjects in Westchester County, New York. Am J Trop Med Hyg (1993) 1.00

Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem Biophys Res Commun (1997) 0.99

Life-threatening complications of empiric ceftriaxone therapy for 'seronegative Lyme disease'. South Med J (1991) 0.99

Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother (2001) 0.99

The acute monocytic leukemias: multidisciplinary studies in 45 patients. Medicine (Baltimore) (1980) 0.99

Infection of epicardial pacemaker wires due to Mycobacterium abscessus. Clin Infect Dis (1998) 0.99